anti-CD20

Pharmacyclics Divisional Patent Application Upheld by Calcutta High Court

Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.

Sowmya S Murthy · 10 Sep 2025